G. L. Ray

发表

Preclinical evaluation of a monoclonal antibody targeting the epidermal growth factor receptor as a radioimmunodiagnostic and radioimmunotherapeutic agent

M. Brechbiel, D. Milenic, D. Milenic, 2009, British journal of pharmacology.

Cetuximab: preclinical evaluation of a monoclonal antibody targeting EGFR for radioimmunodiagnostic and radioimmunotherapeutic applications.

M. Brechbiel, D. Milenic, K. Garmestani, 2008, Cancer biotherapy & radiopharmaceuticals.

MRI with Gadolinium‐Based Nanoparticles

M. Brechbiel, G. L. Ray, F. Guérard, 2015 .

Acute skin toxicity associated with proton beam therapy in spine and brain patients

I. Das, Chee-Wai Cheng, J. Buchsbaum, 2014, Journal of Radiation Oncology.

Preparation of cystamine core dendrimer and antibody-dendrimer conjugates for MRI angiography.

M. Brechbiel, D. Milenic, G. L. Ray, 2012, Molecular pharmaceutics.

Pre-Clinical Assessment of 177Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease

M. Brechbiel, P. Albert, D. Milenic, 2011, Pharmaceuticals.

The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer.

Q. Cai, J. Jaboin, B. Lu, 2011, International journal of radiation oncology, biology, physics.

Pediatric Central Nervous System Reirradiation and Tolerance of the Brainstem to High Cumulative Dose

J. Buchsbaum, P. Johnstone, M. McDonald, 2014 .

Definitive treatment of leptomeningeal spinal metastases in children

J. Buchsbaum, P. Johnstone, G. L. Ray, 2013, Pediatric blood & cancer.